Clinical Trial Update: Diacerein on Insulin Secretion in Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating diacerein's effect on insulin secretion in adults with Type 2 Diabetes Mellitus and overweight/obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Diacerein (Diacerein)

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Type 2 Diabetes Mellitus, Overweight | Phase 2 | Status: COMPLETED